BridgeBio Pharma Inc Net Asset Quality Index
BridgeBio Pharma Inc net asset quality index. BridgeBio Pharma Inc (BBIO) has a Net Asset Quality Index of -205.9% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.22 Billion minus total liabilities of $3.72 Billion yields net assets of $-2.51 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See BBIO book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of BridgeBio Pharma Inc (2017–2025)
Net asset quality index of BridgeBio Pharma Inc from 2017 to 2025. This chart shows how BridgeBio Pharma Inc's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the index stands at -205.9%, representing net assets of $-2.51 Billion against total assets of $1.22 Billion USD. Check BridgeBio Pharma Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
BridgeBio Pharma Inc Net Asset Quality Index by Year (2017–2025)
BridgeBio Pharma Inc net asset quality index by year from 2017 to 2025. The table below presents the year-by-year Net Asset Quality Index for BridgeBio Pharma Inc from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see BridgeBio Pharma Inc market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -221.9% | $-2.08 Billion | $936.02 Million | $3.01 Billion | ▼ -63.3 pp |
| 2024 | -158.6% | $-1.46 Billion | $919.34 Million | $2.38 Billion | ▲ +87.2 pp |
| 2023 | -245.7% | $-1.34 Billion | $546.38 Million | $1.89 Billion | ▼ -45.9 pp |
| 2022 | -199.8% | $-1.24 Billion | $623.04 Million | $1.87 Billion | ▼ -114.4 pp |
| 2021 | -85.5% | $-865.58 Million | $1.01 Billion | $1.88 Billion | ▼ -100.8 pp |
| 2020 | 15.3% | $107.89 Million | $703.59 Million | $595.70 Million | ▼ -60.0 pp |
| 2019 | 75.4% | $475.98 Million | $631.68 Million | $155.70 Million | ▲ +97.2 pp |
| 2018 | -21.8% | $-101.50 Million | $464.94 Million | $566.44 Million | ▲ +33.9 pp |
| 2017 | -55.8% | $-54.69 Million | $98.04 Million | $152.73 Million | — |